Active BE 0762.638.249Private limited company

272BIO

Suzanne Tassierstraat 1 ·9052 Gent, Belgium· 5 yrs active

Sector: Vervaardiging van geneesmiddelen (21201)

Conclusion Checked

The computed 12-month bankruptcy probability of 272BIO is 2.2% (moderate). The 2025 annual accounts show negative equity (€-225k) and a net result of €-632k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Key figures

Equity	€-225k
Net result	€-632k
Staff (FTE)	5.2
Active	5 yrs

Snowflake analysis 5 of 5 axes measured · computed by Checked

53 / 100

Mixed profile: strong on profitability, weaker on health.

All 5 axes are computed from data Checked has read.

Health 7

Profitability 100

Solvency 33

Growth 32

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

2.2% Moderate

0%0,5%1,5%4%10%≥25%

Young company +Annual accounts: weaker financial profile +Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags 0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Health barometer FY 2025 · computed

7 / 100 Critical

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Financial overview4 NBB filings

Annual accounts filed on 12-01-2026 with the NBB · fiscal year 2025 · verkort

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

volatile Too volatile to project: the yearly deviation from the trend is ~50% of the level (threshold 35%). We therefore deliberately show no projection line.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

EBITDA

€-531k

-36.6% 22-25

Net profit

€-632k

-38.1% 22-25

Cash flow

€-556k

-31.2% 22-25

Total assets

€710k

-55.1% 22-25

Equity

€-225k

- 22-25

Working capital

€-427k

- 22-25

Employees (FTE)

5

+48.6% 22-25

Staff costs

€590k

+45.5% 22-25

Income taxes

€2k

- 22-25

Debt

€935k

-20.4% 22-25

Debt ≤ 1y

€856k

-27.2% 22-25

Debt > 1y

€0

-100.0% 22-25

Current ratio

0.50

-53.4% 22-25

Quick ratio

0.50

-53.4% 22-25

Solvency

-31.8%

- 22-25

Debt / equity

-4.15

- 22-25

ROE

280.3%

- 22-25

ROA

-89.0%

-207.8% 22-25

Interest coverage

-19.63

-82.7% 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	verkort
Revenue	-
EBITDA	€-531k
Net profit	€-632k
Cash flow	€-556k
Staff costs	€590k
Income taxes	€2k
Dividends	-
Total assets	€710k
Equity	€-225k
Debt	€935k
of which ≤ 1y	€856k
of which > 1y	-
Working capital	€-427k
Employees (FTE)	5.2

Ratios (computed)

	2025
Current ratio	0.50
Quick ratio	0.50
Working capital ratio	-60.1%
Solvency	-31.8%
Debt / equity	-4.15
Long-term debt ratio	-
Interest coverage	-19.63
Gross margin	-
Net margin	-
ROA	-89.0%
ROE	280.3%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €280k · 39.5% Current assets €429k · 60.5%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€710k
Fixed assets	21/28	€280k
Tangible fixed assets	22/27	€262k
Financial fixed assets	28	€19k
Current assets	29/58	€429k
Amounts receivable within one year	40/41	€62k
Cash & bank	54/58	€351k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€710k
Equity	10/15	€-225k
Contributions / capital	10/11	€1.21M
Accumulated profits (losses)	14	€-1.44M
Amounts payable	17/49	€935k
Amounts payable within one year	42/48	€856k
Trade debts payable within one year	44	€156k
Income statement
Gross operating margin	9900	€104k
Operating result	9901	€-606k
Financial income	75	€3k
Financial charges	65	€27k
Result before taxes	9903	€-630k
Income taxes	67/77	€2k
Net result for the period	9904	€-632k
Result to be appropriated	9905	€-632k

You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Directors & mandates 3 directors

Directors derived from a single State Gazette act, under verification

All 3 current directors first appear in the same act (24145194). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.

Current directors & mandates

Christine Labeur
Non-statutory director
State Gazette act 24145194 (09-10-2024)

Current
09-07-2024 → present
Lizbeth Littlewood
Non-statutory director
State Gazette act 24145194 (09-10-2024)

Current
09-07-2024 → present
Thomas Hayward
Non-statutory director
State Gazette act 24145194 (09-10-2024)

Current
09-07-2024 → present

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Legal Structure

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Private limited company(610)
Incorporation	28-01-2021
Status	Active
Postal code	9052

Establishment units 1 location

272BIO

Suzanne Tassierstraat 1, 9052 GentVervaardiging van geneesmiddelen

since 20212.313.417.534

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
44082B0667/00A000	Flanders	6,161 m²	1 · 1,560 m²	-

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 5 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026

12-01-2026

NBB filing Annual accounts filed

fiscal year 2025 · verkort

2025

30-01-2025

NBB filing Annual accounts filed

fiscal year 2024 · verkort

2024

09-10-2024

State Gazette act Director changes

31-01-2024

NBB filing Annual accounts filed

fiscal year 2023 · verkort

2023

06-02-2023

NBB filing Annual accounts filed

fiscal year 2022 · verkort

Belgisch Staatsblad, acts 1 acts

All acts · 1 updated 1 year ago

2024

09-10-2024 4 directors appointed Director changes

Thomas Hayward, Niet-statutair bestuurder
Christine Labeur, Niet-statutair bestuurder
Lizbeth Littlewood, Niet-statutair bestuurder
BV Crowe Spark Accountants en Belastingadviseurs, Dagelijks bestuur

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "director_in",
      "role": "niet_statutaire_bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas Hayward",
        "address": "SL6 9 XH Cookham, Maidenhead The Coach House Ferry Lane",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2024-07-09",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "niet_statutaire_bestuurder",
      "person": {
        "rrn": null,
        "name": "Christine Labeur",
        "address": "Stijn Streuvelsstraat 28, 8000 Brugge",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2024-07-09",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "niet_statutaire_bestuurder",
      "person": {
        "rrn": null,
        "name": "Lizbeth Littlewood",
        "address": "CT14 0JG Tilmanstone, Deal Mount Pleasant, Vicarage Lane",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2024-07-09",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": "0466.871.391",
        "name": "BV Crowe Spark Accountants en Belastingadviseurs",
        "address": "Sneeuwbeslaan 14, 2610 Antwerpen",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-10-09",
    "filing_date": null,
    "act_kind_objet": "Benoemingen"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-07-09",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-07-09",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-07-09",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-07-09",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0762.638.249",
    "name_full": "272BIO",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0466.871.391",
    "org_name": "BV Crowe Spark Accountants en Belastingadviseurs",
    "person_name": null,
    "org_rep_person_name": "Peter Empsten",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "de notulen van de algemene vergadering dd. 09/07/2024"
  ],
  "corrected_publication_numac": null
}

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Company registry (CBE) Crossroads Bank

Activities

Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201

Primary activity highlighted.

Names & trade names

Legal nameNL

272BIO

Registered office

Suzanne Tassierstraat 1

9052 Gent, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Comparable size · 26 of 148 companies in this sector with filed accounts

MITHRA PHARMACEUTICALS CDMO BE 0534.912.933 · Liège

Groovy.Bio BE 0776.937.633 · Antwerpen

OLYS Pharma BE 0754.895.372 · La Hulpe

BelCoPhar BE 0789.518.434 · Kalmthout

ASTEL MEDICA BE 0472.890.044 · Tinlot